Ascorbic Acid Clinical Trial - 10 More Participants Needed

[Guest guest]

If you're interested...

Final Enrollment of Participants for

Ascorbic Acid Clinical Trial

Ten additional participants are needed to complete the enrollment for the

High-dose Ascorbic Acid Clinical Trial now underway at three locations: Wayne

State University (Detroit, MI), s Hopkins University (Baltimore, MD), and

the University of Rochester (Rochester, NY).

Ascorbic acid is also known as vitamin C and has been successfully used to treat

a laboratory model of CMT1A. The purpose of this study is to evaluate whether

high doses of ascorbic acid have any effect on Charcot-Marie-Tooth disease type

1A (CMT1A) in humans.

Enrollment for the study will end on March 31, 2009.

Please go to http://www.charcot-marie-tooth.org/AA_Announce.php,

if you are interested in participating and would like more information.

(Funding for this study has been provided by the Charcot-Marie-Tooth Association

and the Muscular Dystrophy Association.)